Technology · 47 views
Allen Institute’s big new bet: $200M effort aims to go from mapping the brain to treating disease
The Allen Institute is launching a $200 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, and ALS.
Summary
The Allen Institute is launching a $200 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, and ALS. It marks the first time the Seattle research organization, founded by Paul Allen in 2003, has made treating disease its goal.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Technology
Continue reading recent Technology coverage
- Apple CEO says the company doesn’t ‘want to ship AI for AI’s sake’Continue reading
- Judge allows NAACP lawsuit over xAI data center pollution to move forwardContinue reading
- Get in the spirit with these horrors from YouTubeContinue reading
- Why your Apple AirPods won't connect to your iPhone and how can you fix itContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow